New polio vaccine trial aims to protect the youngest
NCT ID NCT05654467
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new oral polio vaccine (nOPV3) in healthy young children, infants, and newborns in Panama. The goal is to see if it is safe and triggers a strong immune response compared to the current vaccine. About 1,500 participants will receive either the new or existing vaccine and be monitored for side effects and protection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLIOMYELITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cevaxin - 24 de Diciembre
RECRUITINGPanama City, Panama
-
Cevaxin - Chorrera
RECRUITINGPanama City, Panama
-
Cevaxin-- Avenida Mexico
RECRUITINGPanama City, Panama
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a Virus-Like particle vaccine outsmart polio?
- Can breathing power boost balance and Well-Being in paralympic athletes?
- Polio vaccine showdown: which sequence protects best?
- Virtual walking lifts spirits for those who cannot walk
- AI vs. experts: can a computer judge speech as well as a human?
- Can toddlers get three vaccines at once? new study says yes